Unrecognized Tax Benefits of REGENERON PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
REGENERON PHARMACEUTICALS, INC. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • REGENERON PHARMACEUTICALS, INC. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $1,577,900,000, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,577,900,000 +$264,200,000 +20% 31 Dec 2025 10-K 04 Feb 2026 2025 FY
Q4 2024 $1,313,700,000 +$617,300,000 +89% 31 Dec 2024 10-K 04 Feb 2026 2025 FY
Q4 2023 $696,400,000 +$153,600,000 +28% 31 Dec 2023 10-K 04 Feb 2026 2025 FY
Q4 2022 $542,800,000 +$131,900,000 +32% 31 Dec 2022 10-K 04 Feb 2026 2025 FY
Q4 2021 $410,900,000 +$143,900,000 +54% 31 Dec 2021 10-K 05 Feb 2025 2024 FY
Q4 2020 $267,000,000 +$56,200,000 +27% 31 Dec 2020 10-K 05 Feb 2024 2023 FY
Q4 2019 $210,800,000 +$21,300,000 +11% 31 Dec 2019 10-K 06 Feb 2023 2022 FY
Q4 2018 $189,500,000 +$43,300,000 +30% 31 Dec 2018 10-K 07 Feb 2022 2021 FY
Q4 2017 $146,200,000 +$29,000,000 +25% 31 Dec 2017 10-K 08 Feb 2021 2020 FY
Q4 2016 $117,200,000 +$600,000 +0.52% 31 Dec 2016 10-K 07 Feb 2020 2019 FY
Q4 2015 $116,600,000 +$58,985,000 +102% 31 Dec 2015 10-K 07 Feb 2019 2018 FY
Q4 2014 $57,615,000 +$30,988,000 +116% 31 Dec 2014 10-K 08 Feb 2018 2017 FY
Q4 2013 $26,627,000 +$15,353,000 +136% 31 Dec 2013 10-K 09 Feb 2017 2016 FY
Q4 2012 $11,274,000 +$5,678,000 +101% 31 Dec 2012 10-K 11 Feb 2016 2015 FY
Q4 2011 $5,596,000 -$7,223,000 -56% 31 Dec 2011 10-K 12 Feb 2015 2014 FY
Q4 2010 $12,819,000 31 Dec 2010 10-K 13 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.